Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains
- PMID: 18602718
- DOI: 10.1016/j.jhep.2008.04.017
Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains
Abstract
Background/aims: Nucleic acid testing (NAT) for hepatitis B virus (HBV) DNA in blood donations identified occult HBV infection (OBI) as a potential threat to blood safety.
Methods: A collaborative study was undertaken to explore the molecular basis of OBIs prevalent in Europe in relation to clinical and serological data.
Results: Ninety-one percent of 77 donor samples of European origin HBV DNA positive but HBV surface antigen (HBsAg) negative were confirmed. Viral load ranged between unquantifiable and 5640 IU/mL (median 25 IU/mL). Fifty-two strains were genotyped (14 HBV(A2) and 38 HBV(D)). Compared to HBsAg+ samples, genotype D was significantly more frequent than genotype A2 in OBIs from Poland or Italy (P<0.04). Amino acid substitutions were concentrated in the immunologically active parts of the Pre-S/S proteins (P<0.0001) affecting both cellular CD8 T-cell epitopes and B-cell neutralizing Major Hydrophilic Region epitopes. Substitutions were more frequent in OBIs than in HBsAg+ strains of both genotype D (P<0.001) and A2 (P<0.01), in OBIs of genotype D than A2 in the 'a' region (P<0.001) but not cellular epitopes, and in anti-HBs+ than anti-HBs- OBIs (P<0.001).
Conclusions: Results support the hypothesis that humoral and cellular immune pressure on the HBV envelope proteins are major mechanisms generating OBI.
Similar articles
-
Molecular and serological characterization of hepatitis B virus genotype A and D infected blood donors in Poland.J Viral Hepat. 2010 Jun;17(6):444-52. doi: 10.1111/j.1365-2893.2009.01192.x. Epub 2009 Sep 25. J Viral Hepat. 2010. PMID: 19780948
-
Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain.Transfusion. 2010 Jan;50(1):221-30. doi: 10.1111/j.1537-2995.2009.02343.x. Epub 2009 Aug 4. Transfusion. 2010. PMID: 19682332
-
Molecular characterization of occult hepatitis B cases in Greek blood donors.J Med Virol. 2009 May;81(5):815-25. doi: 10.1002/jmv.21499. J Med Virol. 2009. PMID: 19319945
-
Challenges in hepatitis B detection among blood donors.Curr Opin Hematol. 2011 Nov;18(6):461-6. doi: 10.1097/MOH.0b013e32834bac10. Curr Opin Hematol. 2011. PMID: 21912252 Review.
-
Recent developments in the diagnosis and monitoring of HBV infection and role of the genetic variability of the S gene.Expert Rev Mol Diagn. 2005 Jan;5(1):75-91. doi: 10.1586/14737159.5.1.75. Expert Rev Mol Diagn. 2005. PMID: 15723594 Review.
Cited by
-
Ultradeep Sequencing for Detection of Quasispecies Variants in the Major Hydrophilic Region of Hepatitis B Virus in Indonesian Patients.J Clin Microbiol. 2015 Oct;53(10):3165-75. doi: 10.1128/JCM.00602-15. Epub 2015 Jul 22. J Clin Microbiol. 2015. PMID: 26202119 Free PMC article.
-
Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation.Virol J. 2016 May 5;13:76. doi: 10.1186/s12985-016-0533-3. Virol J. 2016. PMID: 27150469 Free PMC article.
-
An overview of occult hepatitis B virus infection.World J Gastroenterol. 2011 Apr 21;17(15):1927-38. doi: 10.3748/wjg.v17.i15.1927. World J Gastroenterol. 2011. PMID: 21528070 Free PMC article. Review.
-
Diagnostic algorithm for HBV safe transfusion.Blood Transfus. 2009 Jul;7(3):174-82. doi: 10.2450/2008.0062-08. Blood Transfus. 2009. PMID: 19657480 Free PMC article. Review. No abstract available.
-
Characteristics of escape mutations from occult hepatitis B virus infected patients with hematological malignancies in South Egypt.World J Hepatol. 2017 Mar 28;9(9):477-486. doi: 10.4254/wjh.v9.i9.477. World J Hepatol. 2017. PMID: 28396718 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials